• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int Immunol . Effect of pre-vaccination blood and T-cell phenotypes on antibody responses to COVID-19 mRNA vaccine

tetano

Editor, Senior Moderator
Int Immunol


. 2025 Mar 20:dxaf013.
doi: 10.1093/intimm/dxaf013. Online ahead of print. Effect of pre-vaccination blood and T-cell phenotypes on antibody responses to COVID-19 mRNA vaccine

Yu Hidaka[SUP] 1 [/SUP], Norihide Jo[SUP] 2 3 [/SUP], Osamu Kikuchi[SUP] 4 5 6 [/SUP], Masaru Fukahori[SUP] 7 8 [/SUP], Takeshi Sawada[SUP] 7 8 [/SUP], Yutaka Shimazu[SUP] 7 8 [/SUP], Masaki Yamamoto[SUP] 9 [/SUP], Kohei Kometani[SUP] 2 [/SUP], Miki Nagao[SUP] 9 [/SUP], Takako E Nakajima[SUP] 7 8 [/SUP], Manabu Muto[SUP] 4 5 8 [/SUP], Satoshi Morita[SUP] 1 [/SUP], Yoko Hamazaki[SUP] 2 10 [/SUP]



Affiliations
Abstract

Despite the high effectiveness of the coronavirus disease (COVID-19) mRNA vaccines, both immunogenicity and reactogenicity show substantial interindividual variability. One key challenge is predicting high and low responders using easily measurable parameters. In this study, we performed multivariate linear regression analysis, which allows adjustment for confounding, to explore independent predictive factors for antibody responses. Using data from 216 healthy vaccinated donors aged 23-81 years, we evaluated baseline characteristics, pre-vaccination blood and T-cell phenotypes, and post-vaccination T-cell responses as variables, with anti-receptor-binding domain (RBD) immunoglobulin G (IgG) titers following two doses of BNT162b2 vaccination as the primary outcome. Consistent with previous reports, higher age, a history of allergic disease, and autoimmune disease were associated with lower peak IgG titers. Additionally, the frequencies of interferon-γ+ spike-specific CD4+ T cells (T-cell response) following the first vaccination strongly correlated with higher IgG responses, while those of pre-existing spike-reactive T cells showed no association with peak IgG titers. Furthermore, we identified lower percentages of naïve CD8+ T cells, lower hemoglobin levels, lower lymphocyte counts, and higher mean corpuscular volume as independent pre-vaccination predictors of lower peak IgG levels. Notably, the frequency of naïve CD8+ T cells showed a positive correlation with the peak IgG levels even in univariate analysis. These findings contribute to the individualized prediction of mRNA vaccine efficacy and may provide insights into the mechanisms underlying individual heterogeneity in immune responses.

Keywords: SARS-CoV-2; immunogenicity; multivariate linear regression analysis; prediction of vaccine response; vaccine efficacy.

 
Back
Top Bottom